O. Kisker

4.3k citations
43 papers · 3.3k indexed · 1 hit paper · h-index 28

O. Kisker

43 papers receiving 3.2k citations

Hit Papers

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After ...7262008202620142020200400600

Peers

O. Kisker
Comparison fields: 5 of 103
  • Oncology 2.0k
  • Hepatology 492
  • Cancer Research 620
  • Pulmonary and Respiratory Medicine 876
  • Pathology and Forensic Medicine 376
Replace Mohamed Hebbar with:
Mohamed Hebbar France
Masao Kameyama Japan
Maurizio Cosimelli Italy
Manfred P. Lutz Germany
Ray‐Hwang Yuan Taiwan
Filippo Pietrantonio Italy
Chiara Carlomagno Italy
Alexander Laird United States
Ilhan Celik Germany
Jorge Barriuso United Kingdom
O. Kisker relative to Mohamed Hebbar France Mohamed Hebbar's profile →
Citations per field
00.5×1.5×
Mohamed Hebbar · 1×
Citations per year

Countries citing papers authored by O. Kisker

Since Specialization
Citations

This map shows the geographic impact of O. Kisker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Kisker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Kisker more than expected).

Fields of papers citing papers by O. Kisker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Kisker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Kisker. The network helps show where O. Kisker may publish in the future.

Co-authorship network

The 25 scholars most cited alongside O. Kisker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with O. Kisker Line = papers co-authored together O. Kisker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200972
2
The crystal study: Assessment of the predictive value of KRAS status on clinical outcome in patients with mcrc receiving first-line treatment with cetuximab or cetuximab plus folfiri
200811
3 20074
4
Cetuximab dose-escalation study in patients with metastatic colorectal cancer (MCRC) with no or slight skin reactions on cetuximab standard dose treatment (Everest): Preliminary PK and efficacy data of a randomized study
20067
5 2003100
6 2003119
7 200235
8 200225
9 20025
10 200021
11 2000227
12 199874
13 19972
14
The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
199735
15 199720
16 199727
17 199630
18 199568
19 199544
20 199440

About O. Kisker

O. Kisker is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 43 papers that have together received 3.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Angiogenesis and VEGF in Cancer (10 papers), Cancer, Hypoxia, and Metabolism (8 papers), Neuroendocrine Tumor Research Advances (7 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (6 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Oncology (2.0k citations), Hepatology (492 citations) and Cancer Research (620 citations). O. Kisker has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Evelyn Flynn, Judah Folkman, Eric Van Cutsem, Μ. Rothmund, Philip J. Hogg, A. Zielke, Yves Humblet, M. E. Vega-Villegas, Steven Pirie‐Shepherd and Sabine Tejpar. Their work appears in journals such as Journal of Clinical Oncology, World Journal of Surgery, Annals of Oncology, British journal of surgery and Surgical Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026